ClearPoint Neuro, Inc. provided revenue guidance for the full year 2024. For the period, Company expects revenues to be between $28 million and $32 million, representing growth between 17% and 33%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | -0.18% | +1.88% | -20.18% |
Apr. 30 | Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory | MT |
Apr. 29 | ClearPoint Gets FDA Clearance For Neurosurgical Equipment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.18% | 147M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.51% | 62.09B | |
+4.81% | 50.88B | |
+10.56% | 50.8B | |
-0.24% | 40.64B | |
+24.99% | 31.59B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc. Provides Revenue Guidance for the Full Year 2024